Anyone who's already invested in Clarity obviously has done a fair amount of research, and would know much or all of what Alan refers to in this interview.
But for anyone who is new to the Company this interview is an excellent introduction and summary. Besides the very conservative approach to research and development that clearly underpins Clarity for its existing work in prostate cancer, it also emphasises the likelihood of developing many other products for other cancers, AND the likely takeover of the Company in time to a Big Pharma, with deep pockets.
IMO, with a market cap around US$0.75 billion, this clearly has a lot further to run just to catch up to the recent takeover target values referred to by Alan in the interview - at the upper level it could be well beyond 3 x $4.35!
The A$150 million cash in its coffers provides Clarity with a fantastic runway to build upon its current product base.
Anyone who's already invested in Clarity obviously has done a...
-
- There are more pages in this discussion • 70 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.60 |
Change
-0.250(5.15%) |
Mkt cap ! $1.433B | |||
| Open | High | Low | Value | Volume |
| $4.84 | $5.02 | $4.30 | $12.45M | 2.676M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3000 | $4.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.62 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |